Takeda inviting banks to join $31B Shire loan deal — 3 insights

Takeda Pharmaceuticals invited banks in Japan and internationally to participate in the syndication process for Takeda’s $30.85 billion loan as it prepares to purchase Shire, Bloomberg reports.

Advertisement

Here’s what you should know.

1. The syndication allows lenders an opportunity to lend money to Takeda for the Shire purchase.

2. Bloomberg reports investing is not without risk, as Takeda had its debt rating downgraded to A2 by Moody’s Investors Service earlier this month.

3. Unnamed sources report Takeda is asking lenders to commit to at least $500 million to join in the syndication.

More articles on supply chain:
7 things for ASC leaders to know for Thursday — May 24, 2018
Ransomware attacks surge in healthcare; surgical groups & orthopedic partners impersonated — 6 report findings
3 strategies for improving patient safety in ASCs

Advertisement

Next Up in Supply chain

Advertisement

Comments are closed.